» Authors » Dirk Mueller

Dirk Mueller

Explore the profile of Dirk Mueller including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 46
Citations 1086
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Wein B, Seleznova Y, Mueller D, Naumann M, Loeser S, Steffen M, et al.
Int J Cardiol Heart Vasc . 2023 Oct; 49:101281. PMID: 37886218
Background: For patients with acute myocardial infarction (AMI), direct coronary angiography (CA) is recommended, while for non-AMI patients, the diagnostic work-up depends on clinical criteria. This analysis provides initial prospective...
2.
Goertz L, Simoes Correa Galendi J, Kabbasch C, Schlamann M, Pennig L, Froelich M, et al.
Clin Neuroradiol . 2023 Jun; 33(4):1075-1086. PMID: 37368089
Purpose: Information about the cost-effectiveness of a certain treatment is relevant for decision-making and healthcare providers. This study compares the cost-effectiveness of the novel Woven Endobridge (WEB) for intracranial aneurysm...
3.
Wein B, Seleznova Y, Mueller D, Naumann M, Loeser S, Artmann J, et al.
Int J Cardiol Heart Vasc . 2023 Apr; 46:101203. PMID: 37091914
Background: With 900'000 coronary angiographies (CA) per year, Germany has the highest annual per capita volume in Europe. Until now there are no prospective clinical data on the degree of...
4.
Langbein T, Kulkarni H, Schuchardt C, Mueller D, Volk G, Baum R
Diagnostics (Basel) . 2022 Aug; 12(8). PMID: 36010276
Purpose: PSMA-targeted radioligand therapy (PRLT) is a promising treatment option for patients with metastatic castration-resistant prostate cancer (mCRPC). However, a high uptake of the radiopharmaceutical in the salivary glands (SG)...
5.
Niessl C, Boulesteix A, Oh J, Palm K, Schlingmann P, Wygoda S, et al.
Mol Genet Metab . 2022 Jul; 136(4):268-273. PMID: 35835062
Infantile nephropathic cystinosis, due to impaired transport of cystine out of lysosomes, occurs with an incidence of 1 in 100-200,000 live births. It is characterized by renal Fanconi syndrome in...
6.
Baum R, Schuchardt C, Singh A, Chantadisai M, Robiller F, Zhang J, et al.
J Nucl Med . 2021 Jun; 63(3):415-423. PMID: 34168013
Fibroblast activation protein (FAP) is a promising target for diagnosis and therapy of numerous malignant tumors. FAP-2286 is the conjugate of a FAP-binding peptide, which can be labeled with radionuclides...
7.
Ahrens P, Mueller D, Siebenlist S, Lenich A, Stoeckle U, Sandmann G
BMC Musculoskelet Disord . 2018 Nov; 19(1):413. PMID: 30474545
Background: Radio frequency ablation devices have found a widespread application in arthroscopic surgery. However, recent publications report about elevated temperatures, which may cause damage to the capsular tissue and especially...
8.
Kulkarni H, Singh A, Langbein T, Schuchardt C, Mueller D, Zhang J, et al.
Br J Radiol . 2018 May; 91(1091):20180308. PMID: 29762048
Alterations at the molecular level are a hallmark of cancer. Prostate cancer is associated with the overexpression of prostate-specific membrane antigen (PSMA) in a majority of cases, predominantly in advanced...
9.
Baum R, Kulkarni H, Singh A, Kaemmerer D, Mueller D, Prasad V, et al.
Oncotarget . 2018 Apr; 9(24):16932-16950. PMID: 29682195
Introduction: Peptide receptor radionuclide therapy (PRRT) of patients with somatostatin receptor expressing neuroendocrine neoplasms has shown promising results in clinical trials and a recently published phase III study. Methods: In...
10.
Gaertner J, Siemens W, Meerpohl J, Antes G, Meffert C, Xander C, et al.
BMJ . 2017 Jul; 357:j2925. PMID: 28676557
 To assess the effect of specialist palliative care on quality of life and additional outcomes relevant to patients in those with advanced illness. Systematic review with meta-analysis. Medline, Embase, Cochrane...